#doctor — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #doctor, aggregated by home.social.
-
DATE: August 13, 2026 at 04:30AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: What patients actually think about ‘minimally invasive’ brain implants
Scroll through the flashy websites of neurotechnology startups and a phrase repeats again and again: “minimally invasive.”
“The term is fuzzy, problematic,” said Anna Wexler, a medical ethics and health policy professor at the University of Pennsylvania Perelman School of Medicine. “Is it physical invasiveness? We’re not sure, it’s a fraught term.”
The fuzziness hasn’t stopped most brain-computer interface startups from deploying it in a bid to differentiate their devices from others in development. Synchron, Motif Neurotech, Precision Neuroscience, and Merge Labs all use it liberally. Journalists sometimes repeat the spin.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
CVE Alert: CVE-2026-85402 - code-projects - Doctor Appointment System - https://www.redpacketsecurity.com/cve-alert-cve-2026-85402-code-projects-doctor-appointment-system/
#OSINT #ThreatIntel #CyberSecurity #cve-2026-85402 #code-projects #doctor-appointment-system
-
Doctor Strange and Doctor Doom: Triumph and Torment Review: Doom Walks Into Hell and Marvel Magic Hits Different
Roger Stern, Mike Mignola, Mark Badger, and Jim Novak turn Doctor Strange and Doctor Doom: Triumph and Torment into a sinister Marvel classic...
https://comiccrusaders.com/reviews/comic-reviews/doctor-strange-doctor-doom-triumph-torment-review/
#classic Marvel comics #doctor doom #doctor strange #Mark Badger #marvel comics #Mephisto #Mike Mignola #Roger Stern #Triumph and Torment -
Doctor Strange and Doctor Doom: Triumph and Torment Review: Doom Walks Into Hell and Marvel Magic Hits Different
Roger Stern, Mike Mignola, Mark Badger, and Jim Novak turn Doctor Strange and Doctor Doom: Triumph and Torment into a sinister Marvel classic...
https://comiccrusaders.com/reviews/comic-reviews/doctor-strange-doctor-doom-triumph-torment-review/
#classic Marvel comics #doctor doom #doctor strange #Mark Badger #marvel comics #Mephisto #Mike Mignola #Roger Stern #Triumph and Torment -
DATE: September 3, 2026 at 09:18AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: OpenEvidence launches new family of AI models
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Good morning health tech readers!
Today, a look at how some generative AI medical devices are getting on the market quickly. Plus: OpenEvidence’s new AI models and some hubbub about OpenAI and Epic.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
DATE: September 3, 2026 at 09:18AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: OpenEvidence launches new family of AI models
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Good morning health tech readers!
Today, a look at how some generative AI medical devices are getting on the market quickly. Plus: OpenEvidence’s new AI models and some hubbub about OpenAI and Epic.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
DATE: September 3, 2026 at 09:18AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: OpenEvidence launches new family of AI models
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Good morning health tech readers!
Today, a look at how some generative AI medical devices are getting on the market quickly. Plus: OpenEvidence’s new AI models and some hubbub about OpenAI and Epic.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
DATE: September 3, 2026 at 09:18AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: OpenEvidence launches new family of AI models
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Good morning health tech readers!
Today, a look at how some generative AI medical devices are getting on the market quickly. Plus: OpenEvidence’s new AI models and some hubbub about OpenAI and Epic.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
https://www.europesays.com/ie/670166/ US medical groups issue vaccine guidance, urge jabs for flu, COVID and RSV | Coronavirus pandemic News #CoronavirusPandemic #Courts #Doctor'sNote #Éire #Government #Health #IE #Ireland #News #UnitedStates #US&Canada
-
DATE: September 3, 2026 at 04:30AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
As the Food and Drug Administration wrestles with how to regulate medical devices that rely on generative artificial intelligence to make decisions about care, it’s provisionally allowing some developers to launch their products on the market.
AI products from Cadence and Limbic are among four devices recently accepted into the agency’s TEMPO pilot program that will allow digital health companies to release their products without marketing authorization.
The pilot is intended to beef up the number of technologies available for the Medicare ACCESS model, an experiment in paying for technology to help beneficiaries manage chronic conditions. But it also offers the agency and companies the opportunity to experiment with AI regulation in the real world.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
DATE: September 3, 2026 at 04:30AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
As the Food and Drug Administration wrestles with how to regulate medical devices that rely on generative artificial intelligence to make decisions about care, it’s provisionally allowing some developers to launch their products on the market.
AI products from Cadence and Limbic are among four devices recently accepted into the agency’s TEMPO pilot program that will allow digital health companies to release their products without marketing authorization.
The pilot is intended to beef up the number of technologies available for the Medicare ACCESS model, an experiment in paying for technology to help beneficiaries manage chronic conditions. But it also offers the agency and companies the opportunity to experiment with AI regulation in the real world.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
DATE: September 3, 2026 at 04:30AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
As the Food and Drug Administration wrestles with how to regulate medical devices that rely on generative artificial intelligence to make decisions about care, it’s provisionally allowing some developers to launch their products on the market.
AI products from Cadence and Limbic are among four devices recently accepted into the agency’s TEMPO pilot program that will allow digital health companies to release their products without marketing authorization.
The pilot is intended to beef up the number of technologies available for the Medicare ACCESS model, an experiment in paying for technology to help beneficiaries manage chronic conditions. But it also offers the agency and companies the opportunity to experiment with AI regulation in the real world.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
DATE: September 3, 2026 at 04:30AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
As the Food and Drug Administration wrestles with how to regulate medical devices that rely on generative artificial intelligence to make decisions about care, it’s provisionally allowing some developers to launch their products on the market.
AI products from Cadence and Limbic are among four devices recently accepted into the agency’s TEMPO pilot program that will allow digital health companies to release their products without marketing authorization.
The pilot is intended to beef up the number of technologies available for the Medicare ACCESS model, an experiment in paying for technology to help beneficiaries manage chronic conditions. But it also offers the agency and companies the opportunity to experiment with AI regulation in the real world.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
Never make thy Physician thy heir.
[Non far ma medico tuo herede.]James Howell (c. 1594–1666) Welsh historian, writer, aphorist
Paroimiographia [Παροιμιογραφία]: Proverbs, or, Old Sayed Sawes & Adages, “Proverbs in Italian” (1659)
[compiler]More about this quote: wist.info/howell-james/85394/
#quote #quotes #quotation #qotd #jameshowell #proverb #conflictofinterest #doctor #healthcare #heir #incentive #inheritance #medicalcare #physician #selfinterest #vulnerability
-
DATE: August 10, 2026 at 10:52AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: Ban prior auth? And hospitals cut jobs
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.
The cyclosporiasis outbreak means a lot of poop has been tested. Spare a thought for the lab professionals who are up to their knees in you-know-what. Feel free to send me samples … of your thoughts and tips only, come on now: [email protected].
Should prior authorization be eliminated?
Hannah Garden-Monheit is asking for a simple health care policy change: ban prior authorizations (for the most part).
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
https://www.europesays.com/ie/629552/ New drug delivers promising survival gains in pancreatic cancer #Adenocarcinoma #cancer #chemotherapy #ClinicalTrial #Diarrhea #doctor #Drugs #Éire #Gene #Genes #Health #IE #Ireland #medicine #Mutation #oncology #PancreaticCancer #pH #RadiationTherapy #radiotherapy #RasProteins #Surgery #therapy #Tumor
-
DATE: June 9, 2026 at 04:30AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: Wearables, and the flood of data they generate, inch closer to entering the clinic
URL: https://www.statnews.com/2026/06/09/wearables-data-oura-whoop-clinical-integration/?utm_campaign=rss
A major selling point for wearable devices is the promise that they’ll help identify hidden health conditions before they lead to major harm. But a nagging issue has been the connection to clinician guidance when a smartwatch or ring raises the alarm.
To help address this issue, wearable makers Oura and Whoop recently announced they’ll make it possible for users to connect virtually with doctors directly from their apps. While the move could represent the first step in the long-awaited adoption of consumer health data by traditional clinical care, experts cautioned that the bar for data in clinical decision-making is higher than for simple wellness purposes. The Food and Drug Administration has only authorized a handful of wearable features for clinical use, and the evidence base for using wearable data to inform medical care is nascent. Widespread use by clinicians will take considerably more work.
“This was an inevitable development,” said Ida Sim, a physician and professor at the University of California, San Francisco, who studies how to make best use of consumer health data. “We’ve got these sensors that have ostensibly valuable data … but we haven’t even begun to tap into the real clinical value.”
Continue to STAT+ to read the full story…
URL: https://www.statnews.com/2026/06/09/wearables-data-oura-whoop-clinical-integration/?utm_campaign=rss
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
Doctor’s alcohol tip that ‘could save your life’ goes viral on TikTok
https://web.brid.gy/r/https://www.upworthy.com/how-long-alcohol-stays-in-our-system-tip-ex1/
-
#LetterOfTheWeek
Should leisure travel be allowed for those appealing against conviction?
🧐"Why shld te doctor be allowed to travel for leisure.? Te #patient’s family & friends may still be #grieving over the #loss of their loved one, & must be pained to learn tt the #convicted #doctor is allowed to go overseas for a 14-day #holiday as if all were normal.
Any person charged & on bail, or after conviction & sentencing . shld not be allowed to travel #overseas for leisure"⚖️
https://www.straitstimes.com/opinion/forum/forum-should-leisure-travel-be-allowed-for-those-appealing-against-conviction -
#dwr #freetube #fedibikes #MdRddG #NI #MdRzA #obob #fahrrad #FahrradStattPorsche #frostpendeln #Doctor #Who
#Welt! Bist du noch da?
Nein, aber ich sage es mal so:
“Meine #Zeit, war die Zeit, als man noch Zeit hatte sich Zeit zu nehmen und sich trotzdem zeitig auf den Weg machte!”
Also, gestern einen #Termin mehr gehabt, so dass ich mich heute doch auf das #Rad schwingen und den #Arbeitsweg genießen kann.
1/2
-
"Judge Ong Hian Sun said tt Chan had betrayed the trust reposed in him as a #doctor, & he had been motivated by #monetary gain.. Chan still has three other pending charges under the #Health Products Act. Among other things, he was charged in 2022 with possessing #expired injection #ampoules of adrenaline & a heartburn relief #drug at Revival #Medical & #Aesthetics Centre in March 2019. These charges will be dealt with at a later date"
🤔Does he deserve to remain a doctor?!
https://www.straitstimes.com/singapore/courts-crime/doctor-who-performed-negligent-act-that-led-to-patients-death-gets-18-months-jail -
Unlikely Hantavirus came from Tierra del Fuego, official says
Patients on a luxury cruise ship hit by a deadly hantavirus outbreak could not have been infected in Argentina's southernmost Tierra del Fuego province, said Juan Petrina, director of epidemiology and environmental health for the province. #hantavirus #who #cruiseship #health #spain #doctor #medic #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world:…
https://fllics.com/en/video/unlikely-hantavirus-came-from-tierra-del-fuego-official-says/
-
Hantavirus-hit ship captain announces first death: April 12 video
Video shared on social media shows the captain of a cruise ship affected by a hantavirus outbreak informing passengers on April 12 that one person had died on board, saying the death was believed to be due to natural causes and was not infectious. #hantavirus #cruiseship #health #spain #doctor #medic #News #Reuters #Newsfeed Read the story here: 👉 Subscribe:
https://fllics.com/en/video/hantavirus-hit-ship-captain-announces-first-death-april-12-video/
-
People from hantavirus-hit ship arrive in the Netherlands
A plane carrying three people evacuated from the luxury cruise ship hit by a deadly hantavirus outbreak landed at Schiphol airport in the Netherlands. #hantavirus #cruiseship #health #spain #doctor #medic #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on X: Follow Reuters on Instagram:
https://fllics.com/en/video/people-from-hantavirus-hit-ship-arrive-in-the-netherlands/
-
@MikeDunnAuthor This needs to become a daily, year around event, not just once a year...
https://www.thestranger.com/news/once-a-year-seattle-center-becomes-a-medical-center/
#Clinic #Health #Healthcare #Medical #Bankruptcy #MedicalBankruptcy #Dentist #Doctor #DoctorsWithoutBorders #Seattle #KingCounty #SeattleCenter #Medicare
-
Preventative Medicine, or the Manufacture of Patients?
There is a sentence every American patient has heard at the dentist’s chair, the cardiologist’s office, the primary-care visit, and the pharmacy counter. It arrives in a tone of grave responsibility: We caught this early. What follows is a crown, an echocardiogram, a statin, a stress test, a referral, a follow-up appointment, and a copay. The word “preventative” has come to function as a moral shield around a billing code. To question whether the recommended intervention is necessary is treated as ingratitude toward a profession that, the implication goes, only wants to keep you alive.
The trouble is that the evidence for many of these interventions is weaker than the assured tone of the recommending clinician suggests, and the financial structure of American medicine rewards the recommendation regardless of whether the evidence supports it. A 2019 JAMA review by Shrank and colleagues estimated annual waste in U.S. health spending at $760 billion to $935 billion, roughly a quarter of total expenditures, with overtreatment and low-value care alone accounting for $76 billion to $101 billion of that figure. Administrative complexity contributes another $266 billion. Pricing failures contribute $230 to $241 billion. These are the numbers in the system’s own peer-reviewed literature, produced by health-services researchers reading their own data.
Consider the dental crown. A 2020 study by Holden and colleagues, published in Community Dentistry and Oral Epidemiology, surveyed dentists who reported widespread peer-observed overtreatment driven by what the authors called the “selling culture” of practice-management courses that teach acceptance-rate optimization. KFF Health News documented Medicaid reimbursement structures that pay three to six times more for nickel-chromium steel crowns than for fillings, an obvious incentive to crown rather than restore. Two of the largest American dental chains, operating under the Kool Smiles and Small Smiles brands, settled federal whistleblower lawsuits alleging unnecessary root canals on Medicaid-enrolled children for roughly $24 million each. The pattern is documented in the Department of Justice settlement record. A three-year-old boy named Gregory, examined by a North American Dental Group office in Ohio, was diagnosed with seven needed root canals; four of the teeth treated were later extracted. The Medicaid bill came to $1,273 against the $61 a check-up and cleaning would have cost. Gregory paid in tooth count. The chain paid a settlement years later, after the journalism caught up with the billing.
Echocardiograms tell the same story in higher-resolution format. The American College of Cardiology, through the Choosing Wisely campaign launched in 2012, listed five cardiac procedures routinely overused, three of which concerned imaging and stress-testing patients without symptoms. The American Society of Echocardiography itself recommends against repeat echocardiograms in stable, asymptomatic patients with a previously normal exam, against echocardiography for preoperative assessment in patients with no cardiac history, and against stress echocardiograms in low-risk asymptomatic adults. A multicenter trial cited by the Journal of Nuclear Cardiology found that 15% of cardiac SPECT studies were inappropriate by the ACC’s own appropriate-use criteria, with the largest single category being detection of coronary artery disease in asymptomatic low-risk patients. A Choosing Wisely Canada review found that asymptomatic low-risk patients account for up to 45% of unnecessary cardiac screening. The professional society of the field that performs the test acknowledges that close to half of its screening volume should not occur. The volume occurs because the equipment is amortized, the slot is scheduled, and the reimbursement code clears.
Salt deserves a more careful answer because the original advice was honest, the science evolved, and the medical establishment has not communicated the evolution well to patients trained to fear the salt shaker. A 2026 systematic review and meta-analysis in Cureus by Alqurain and colleagues, drawing on twenty studies and 306,019 participants, found that sodium restriction reduces mortality risk in patients with essential hypertension, which confirms the original logic for that population. In observational cohorts, however, low sodium intake associates with increased mortality, supporting a J-shaped relationship at the lower extreme. In heart-failure populations specifically, aggressive restriction shows a non-significant trend toward harm. The 2024 European Society of Cardiology guidelines responded to this evidence by setting the sodium target at less than 2 grams per day, framed as realistic and sustainable, and acknowledged that the J-curve effect appears at intakes below that threshold. The honest answer to the question is that the old blanket prohibition was overdrawn, the current evidence supports moderation rather than minimization, and the simplistic counter-claim that “more salt is better” is also wrong. Hypertensives still benefit from reduction. Severely sodium-depleted patients on aggressive diuretics may be harmed by it. Medicine has walked back a categorical claim quietly, without retracting the decades of advice that produced an entire processed-food category labeled “low sodium” and a generation of patients trained to feel guilty about a pinch.
Threshold creep is the marketing arm of preventative medicine, and the documentation of it is now its own academic literature. In May 2003, the Joint National Committee’s seventh report introduced “prehypertension” as a diagnostic category covering blood pressure between 120 and 139 systolic or 80 and 89 diastolic, redrawing the line of disease in a single committee meeting and producing millions of new patients overnight without anyone’s actual blood pressure changing. The American Diabetes Association lowered the hemoglobin A1c threshold for prediabetes to 5.7% in 2010, expanding the population eligible for diabetic surveillance and pharmaceutical preprescription by tens of millions. AbbVie spent more than $75 million on AndroGel marketing in 2012, running an unbranded “Is It Low T?” awareness campaign that, according to a 2017 JAMA Internal Medicine analysis, drove measurable rises in testosterone testing in regions with heavier advertising exposure. The company’s claimed hypogonadism prevalence climbed from roughly one million American men at AndroGel’s FDA approval in 2000 to twenty million at the peak of the campaign, a twentyfold inflation in twelve years that left the actual incidence of medical hypogonadism unchanged and reached well past it into the population of aging men whose declining testosterone is part of normal physiology. JAMA itself published the takedown under the title “Low T as a Template: How to Sell a Disease.” GlaxoSmithKline ran the parallel campaign for restless legs syndrome beginning in 2003, two years before Requip’s FDA approval; sales doubled within a year, climbing from $165 million in 2005 to $330 million in 2006, and the Restless Legs Syndrome Foundation received roughly 45% of its 2005 revenue from the drug companies whose products it was positioned to validate. Ray Moynihan and Alan Cassels named the framework in 2005 in Selling Sickness, which the April 2006 special issue of PLoS Medicine on disease mongering then developed across eleven peer-reviewed articles. The phenomenon is not exotic. The eye doctor who tells the patient with stable elevated intraocular pressure that the chart now reads “pre-glaucoma” is following the same logic, and the rest of the chain follows automatically: category extends, patient enrolls, visit recurs. Nothing about the patient has changed except the box checked on the form.
Colonoscopy is the case where every thread in the argument crosses. The U.S. Preventive Services Task Force recommended initiating screening at age 50 from its 1996 guideline through 2020, then lowered the threshold to 45 in May 2021 in response to documented rises in younger-onset colorectal cancer; the American Cancer Society had already moved earlier, in 2018. The threshold change added roughly 21 million newly eligible Americans to the screening pool. Modeling cited in the USPSTF’s own evidence review estimated that lowering the screening age from 50 to 45 requires 810 additional colonoscopies per 1,000 persons screened in a colonoscopy-based strategy. The procedural revenue for the gastroenterology specialty is substantial, and the financial alignment with maintaining colonoscopy as the preferred modality is direct, even though the USPSTF itself lists fecal immunochemical testing, stool DNA testing (Cologuard from Exact Sciences), and, since the FDA approval of Guardant Health’s Shield in July 2024, plasma-based screening as recommended alternatives. Patients dislike colonoscopy for documented reasons that the marketing apparatus does not address: the day-long bowel preparation is psychologically and physically demanding, the procedure itself requires sedation and a driver, and the complication rate, while small in absolute terms at roughly four perforations and eight major bleeding events per ten thousand procedures, is non-zero on a population that now includes twenty million additional people. Most consequentially, the randomized trial evidence underwriting the marketing is more modest than the marketing suggests. The Nordic-European Initiative on Colorectal Cancer trial, called NordICC, published in the New England Journal of Medicine in October 2022 by Bretthauer and colleagues, randomized 84,585 adults aged 55 to 64 in Poland, Norway, and Sweden either to receive a one-time invitation to colonoscopy or to receive no invitation. At ten years, the intention-to-screen analysis found an 18% relative reduction in colorectal cancer incidence, considerably less than the 50% the trialists had originally hypothesized, and the reduction in colorectal cancer-specific mortality was not statistically significant, with a relative risk of 0.90 and a confidence interval that crossed one. Per-protocol analyses of those who actually attended their colonoscopy were more favorable, but the trial’s headline finding sent a different signal than the volume of screening recommendation would suggest. None of this argues against any individual person choosing colonoscopy. The mass-screening case for choosing colonoscopy at age 45 over the non-invasive alternatives, on a procedure patients dislike with a complication profile that scales with volume, is weaker than the gastroenterology revenue stream depending on it would suggest.
Statins offer a sharper case because the harm signal is undisputed within the literature, including the manufacturers’ own pooled trial data. The 2024 individual-participant-data meta-analysis published in The Lancet Diabetes & Endocrinology by the Cholesterol Treatment Trialists’ Collaboration confirmed what previous summary-level analyses had shown: statin therapy produces a moderate, dose-dependent increase in new diagnoses of type 2 diabetes. The earlier Sattar meta-analysis, with 91,140 participants across thirteen trials, put the relative risk increase at 9%. Preiss and colleagues, comparing high-intensity to moderate-intensity statins across five trials with 32,752 participants, found a 12% increase. Cai and colleagues stratified by LDL-c target and found that when the target was set below 1.8 millimoles per liter, the risk of new-onset diabetes rose by 33%. The Diabetes Prevention Program Outcomes Study, with 3,234 high-risk participants followed for ten years, recorded a 36% cumulative incidence of diabetes among statin users compared with 20% in placebo. Observational meta-analyses, which capture longer follow-up and broader populations than the trials, place the increase as high as 44 to 55%. Statins lower cardiovascular events in patients with established disease. They also produce diabetes in a measurable fraction of users, with the risk concentrated in patients who already carry metabolic risk factors. Both statements are true. Weighing them honestly per patient is the clinical task. The marketing posture, which presented the drugs as harmless tools to be deployed broadly on the basis of a single number called LDL-c, was always incomplete. As the LDL-c target was driven downward more aggressively, the regimen produced more diabetes. This is on record. It has not produced a corresponding pullback in prescribing volume because the prescribing volume is shaped by guideline thresholds, quality metrics tied to insurer reimbursement, and patient anxiety, none of which respond directly to the diabetes incidence data.
The structural question follows from the four clinical cases. Is the American medical system broken, or did it never work? The honest answer is the second. The system was assembled from incompatible parts during the postwar period: a tax-deductible employer-insurance model designed during wartime wage controls, a Medicare program designed to extend Blue Cross logic to the elderly, a Medicaid program designed as charity for the poor, a private fee-for-service architecture designed for solo practitioners, and a hospital-based academic medicine designed for rare disease and surgery. None of these components were designed together. None share an objective function. The result is an apparatus that bills with great competence, codes with great competence, and produces health outcomes that are mediocre by every international comparison the United States has been willing to publish. Life expectancy at birth in the United States is below that of Costa Rica. Maternal mortality runs more than 50% higher than in the next closest wealthy nation. The system is performing as designed; the design has always rewarded volume of billable encounters, and the financial structure pays out for that volume regardless of whether the volume corresponds to improved health.
This is where the moral question becomes unavoidable. Should there be profit in having a healthy body? Some forms of profit are morally legible. A surgeon who removes a tumor has earned compensation. A pharmaceutical firm that develops a drug from molecule to market has earned a return on capital. An infectious-disease specialist who diagnoses a rare presentation has earned the consultation fee. These are professional earnings against a discrete service rendered. The trouble is that American medicine has migrated, over four decades, from the model of compensated service toward the model of recurring revenue extraction. A patient enters a clinical panel. The panel is screened on a schedule. Screening reveals an incidental finding, which generates a workup, which generates a procedure, which generates a follow-up, which generates a maintenance medication, which generates a side effect, which generates a referral. At no point in this chain does anyone need to act in bad faith for the patient to be subjected to a sequence of interventions whose net benefit, as measured by years of life or quality of life, is negligible or negative. The clinician is paid by relative-value-unit production, the hospital by case-mix index, the insurer by per-member-per-month premiums, the drug company by prescription volume. The patient pays a copay at every node and a premium at the front of the chain.
Consider how the mechanism operates without anyone choosing it. The dentist who recommends a crown the tooth does not require is rarely acting in bad faith. The practice-management system quantifies daily production targets and benchmarks the doctor’s work against peer averages, and a clinician below the benchmark has uncomfortable conversations with the practice owner. A cardiologist who orders surveillance echocardiograms in stable asymptomatic patients follows a referral pattern that the practice’s billing coordinator built into the appointment template. A primary-care physician who titrates a statin to a more aggressive LDL-c target works from a quality measure that determines a portion of the practice’s reimbursement. None of these clinicians wakes up wanting to harm the patient. The structure does the harming for them, by making the path of least resistance the path of maximum billing. Preventative medicine, in the modern American sense, has become a euphemism for a procedure pipeline disguised as moral concern.
The technologies themselves have legitimate uses. Statins prevent secondary cardiovascular events in patients who have already had a heart attack, and the evidence for that use case is strong. Echocardiograms in symptomatic patients are diagnostic instruments without which cardiology could not function. Crowns on actually fractured teeth save the tooth and the bite. The correct critique is of population-level deployment without symptom-based indication, of marketing the diagnostic machinery as a moral good when it operates as a revenue mechanism, and of presenting the patient with a recommendation that the system has produced before the clinician walked into the room.
Real prevention exists, and it is recognizable by the absence of profit attached to it. Hand-washing prevents postsurgical infection. Vaccines reduce measles, pertussis, and cervical cancer to historical curiosities. Smoking cessation lowers lung-cancer, stroke, and heart-disease risk. Exercise interrupts nearly every chronic-disease cascade. Sleep allows metabolic recovery. Adequate nutrition starves the inflammatory base state on which most chronic disease feeds. None of these interventions generates significant revenue for the medical system, which is why none of them receives the marketing attention that statins and stress tests and crowns receive. The cheapest preventive measures, which are also the most effective, sit unmarketed because no one profits from them. The most expensive interventions, which range from genuinely beneficial to actively harmful depending on the patient, are heavily marketed because the entire revenue chain depends on their continued use.
A patient who walks into an American clinical encounter today operates in an information environment in which the recommending professional has financial reasons to recommend, the institution has financial reasons to perform, the insurer has financial reasons to negotiate, and no one in the room has direct financial reasons to leave the patient alone. The patient is the only party in the room without a billing code, the substrate on which the codes are inscribed. Until the financial structure changes, the recommendation to question every preventative procedure deserves to be called sober self-interest, supported by the system’s own published evidence about its own published failures. The question to ask the dentist, the cardiologist, the primary-care physician, and the pharmacy counter is the one the system makes hardest to ask: What happens to me if I do nothing? The answer is sometimes serious, sometimes neutral, and sometimes far better than the answer that follows the recommended intervention. Knowing the difference is the work of an adult patient in a system that prefers the patient remain a child.
#bloodPressure #cardiac #dentist #doctor #echocardiogram #glaucoma #health #healthcare #healthyBody #preventativeMedicine #screening #statins -
The Touch Of Fire "She had been in Denver less than a month when a letter arrived, regretfully relaying the news that her father had passed away" Sale: $10.99 to $1.99 by Linda Howard Rating: 4.4/5 (1,899 Reviews) #Romance #Historical #Western #Outlaw #Doctor #Adventure #Love #Suspense #BookSky
The Touch Of Fire -
All doctors in America wear white robes with a red mantle and have the glowing power of God emanating from their hands. They are routinely worshiped as a living God by all who see them.
Jesus, on the other hand, wears a white lab coat and a stethoscope.
So of course it's quite understandable that President Trump confused the two. 🤔
-
DATE: April 1, 2026 at 10:08AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: Insilico Medicine CEO on how best to use AI in drug development
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday.
They remind you to not talk during the movie, but when I saw “Project Hail Mary” last week, I was so alarmed that Ryan Gosling placed two Eppendorf tubes next to each other that I said, aghast, “He didn’t balance the centrifuge — that would have wrecked it…” while my non-scientist friends cracked up.
That one scientific flub aside, it’s still one of the best book-to-film adaptations I’ve seen, maybe ever.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
DATE: March 29, 2026 at 02:06PM
SOURCE: STAT HEALTH TECHTITLE: STAT+: AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion
Alex Zhavoronkov, CEO of Insilico Medicine, can’t stop complimenting Eli Lilly. “Lilly is better in AI than Insilico, and no other company is better in AI than us … except for these guys,” he said.
He insisted he wasn’t saying nice things about Lilly just because the pharma giant has signed a new deal with Insilico that’s worth $115 million up front and approximately $2.75 billion in biobucks, which are contingent on achieving regulatory and commercial milestones. After calling Lilly’s tirzepatide, which he is on, “the best drug ever invented by humans,” he said he’s been consistently singing Lilly’s praises for a year. “Mounjaro makes me so happy every day. I want to develop the next one.”
It looks like Zhavoronkov might have the opportunity to do just that — his AI drug development company’s new deal with Lilly, announced on Sunday, includes rights for the Mounjaro and Zepbound manufacturer to develop, manufacture, and commercialize some of Insilico’s preclinical AI-discovered candidates for oral therapeutics. Though he declined to say which assets Lilly licensed, he said that the company is the “absolutely best partner” for the candidates and that “nobody is better than them” in these disease areas. Insilico’s pipeline webpage recently was updated to note that a candidate targeting GLP-1 has been out-licensed to an undisclosed partner.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
DATE: March 11, 2026 at 09:29AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: This billionaire wants to make science better, especially for AI
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday.
I guess I should really start watching “The Pitt.” It’s made its way into my favorite music newsletter, and my friend also tells me that there was Jeni’s ice cream product placement on the show last week. Who’s got an HBO Max login I can borrow?
Also, speaking of ice cream … does anyone have Louisville, Ky., ice cream recommendations? You know where to find me: [email protected], or at the ice cream stand.
Bold ideas about AI and science
Seemay Chou has my dream job: Giving away $3.5 billion of her and her partner’s money before she dies, and thus getting to decide which scientific projects to fund. (If anyone has even $1 billion and wants to make my dream come true, you know my email!!)
You can read more about Chou’s new nonprofit venture, Radial, in my colleague Allison DeAngelis’ exclusive new story, including great details on the Diffuse project, which is seeking to create the next structural biology database, like the one that birthed AlphaFold.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
+++ 🌱 #Cannabis as 🫀 #Medicine +++
What can the 🚑 #CenterforCannabisMedicine do for you?
Are you a 👩⚕️ #doctor, 💊 #pharmacist, 👩🦽➡️ #patient, or ✍️ #journalist looking for reliable and compact 📚 information on the ⚕️ #medicaluse of cannabis and 🩺 #cannabinoids? ...
🏥 👨⚕️ Dr. med. #FranjoGrotenhermen
https://zentrum-cannabis-medizin.de/en
#Grotenhermen #Cannabismedizin #Hanfwissen #Hanfgeschichten #Hanf #hemp #Gesundheit #Wissenschaft #Weedmob #CSU #CDU #SPD #DIELINKE #Medizin #Wissenschaft #Merz #Klingbeil
-
Stop Replacing Our Doctors!
Physician/anaesthesia assistants are employed more & more, many working beyond their scope. #Patients have #died due to #PAs working above their #competencies
Trusts still advertising for PAs/AAs when role requires a doctor, many of whom face #unemployment
Patients are confused by various ‘consultants’ who are NOT #medically qualified. They think they’re seeing a #doctor
This should NOT be future of #OurNHS!
-
DATE: January 20, 2026 at 06:30PM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
.@AbbottNews' #Tactiflex gains #CEmark
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
DATE: January 15, 2026 at 09:28AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: Emoji infiltrate the medical record 🤦
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Good morning health tech readers!
I may just be an aging millennial, but I sometimes worry my emoji use is…. wrong. That I’m maybe humiliating myself in Slack and inscrutable in the group chat. It’s a minor (devastating) issue in my personal life, but what happens when characters with no universally defined meaning enter our medical records? Read on to our lead story to find out.
Reach me: [email protected]
What do emojis in medical records mean?
A wonderful new study of 218 million clinical notes at Michigan Medicine explores the use of emoji in medical records. Emoji use is still rare — they were in fewer than two notes in every 100,000 notes — but those numbers may be ticking up. A total of 372 distinct emoji were identified. As Katie Palmer notes, the use of the cartoony characters in medical records could impact their interpretability with legal and patient care implications.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
My First Day Of Locum And As A Medical Officer
Related Posts:
- 2026 – The Beginning
- My First Night Shift In Emergency & Trauma | Housemanship Diaries
- Life After Offtag In Emergency & Trauma | Housemanship Diaries
- Day 1 Of My Final Posting – Day 647 Of Housemanship
- Surviving 10 Days Of Tagging | Emergency & Trauma Department
- My Last Shift As A House Officer in Medical | Housemanship Diaries
- Preparing For My Exit From The Medical Posting As A House Officer | Housemanship Diaries
- Surviving The Night Shift In The Medical Posting In General | Housemanship Diaries
- My First Night Shift Covering Medical 4 / Medical 5 / Infectious Disease Ward In Sarawak General Hospital – Housemanship Diaries
- Part 1 – Life As A Peri Medical House Officer In Hospital Umum Sarawak | The Emergency Department
- Appreciation Towards The Medical Officers (MOs) – Housemanship Diaries
- 1 Year Of Housemanship Update – Housemanship Diaries
- Another Good Advice I Will Remember For The Longest Time – Housemanship Diaries
- Enjoying The Journey – Housemanship Diaries
A locum or locum tenens, is a person who temporarily fulfils the duties of another; the term is especially used for physicians or clergy.
– Wikipedia.
The first time I ever tasted or ventured into locum or a so-called “part-time doctor” was on the 3rd of August 2025.
At that time, I was back in my hometown and on a 3-weeks-break post housemanship / internship at a small private clinic, yet to officially begin as a Medical Officer.
While I was in medical school, I would occasionally hear this term “locum” from my fellow seniors or batch mates, lecturers, parents or even friends of my parents. However, in order to locum, one would need to be fully registered with the Malaysian Medical Council (MMC) and possess a valid Annual Practicing Certificate (APC). In short, I had to graduate medical school, finish my internship or housemanship first, then only am I able to dive into this.
Thus, upon acquiring my full MMC and APC licence, I was looking forward to locum. Looking forward to it as well as nervous to dive into this. Thankfully, I had just completed my final rotation in the Emergency and Trauma Department.
In the Emergency and Trauma Department, there are various zones in which the patients would be triaged into in terms of presenting complaints, severity and their vital signs. The least critical in severity would be triaged into Green zone. The Green zone is similar to a clinic setting, thus, it gave me some idea on the type of cases I would be expecting.
My first locum was just 3 hours long, from 7pm till 10pm. I figured that since I am just starting at that time, it would be better to start with minimal hours in order to get used to it and also.. if I would enjoy it.
The clinic was quaint and small but equipped with basic necessities and a scan machine. The only thing that it did not have, was an x-ray facility. The moment I sat down, the patients kept coming back-to-back. As soon as I was done with one, another came.
For a first-timer, I felt it was equivalent to the Green Zone in General Hospital whereby the cases were always there but the patient load was manageable.
However, I was extremely scared.
Mainly afraid that I might accidentally jeopardise the patient’s safety in terms of mismanagement. Thankfully, by 9:30 pm, the clinic assistant stopped accepting new patients and prepared to close the clinic.
For a first experience, it was a good one despite it being rather terrifying for me.
But, we all have to start somewhere and build our confidence, don’t we?
Related Posts:
- 2026 – The Beginning
- My First Night Shift In Emergency & Trauma | Housemanship Diaries
- Life After Offtag In Emergency & Trauma | Housemanship Diaries
- Day 1 Of My Final Posting – Day 647 Of Housemanship
- Surviving 10 Days Of Tagging | Emergency & Trauma Department
- My Last Shift As A House Officer in Medical | Housemanship Diaries
- Preparing For My Exit From The Medical Posting As A House Officer | Housemanship Diaries
- Surviving The Night Shift In The Medical Posting In General | Housemanship Diaries
- My First Night Shift Covering Medical 4 / Medical 5 / Infectious Disease Ward In Sarawak General Hospital – Housemanship Diaries
- Part 1 – Life As A Peri Medical House Officer In Hospital Umum Sarawak | The Emergency Department
- Appreciation Towards The Medical Officers (MOs) – Housemanship Diaries
- 1 Year Of Housemanship Update – Housemanship Diaries
- Another Good Advice I Will Remember For The Longest Time – Housemanship Diaries
- Enjoying The Journey – Housemanship Diaries
YouTube | Instagram | Pinterest | Facebook | Spotify
About Me | Privacy Policy | Contact Me
#article #Articles #Blog #blogging #clinic #clinicLife #dailyprompt #dailyprompt1804 #dailyprompt1828 #dailyprompt1833 #dailyprompt1839 #dailyprompt1843 #dailyprompt1853 #dailyprompt1855 #dailyprompt1861 #dailyprompt1862 #dailyprompt1942 #dailyprompt1946 #dailyprompt1947 #dailyprompt1948 #dailyprompt1951 #dailyprompt1953 #dailyprompt1959 #doctor #hospital #hospitalLife #houseOfficer #housemanship #johorBahru #locum #locumTenens #locuming #Malaysia #medical #medicalOfficer #Medicine #writing
-
DATE: December 19, 2025 at 04:31PM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
RT @BioWorldScience: Researchers discover how #glioblastoma tumors dodge chemotherapy (free w/ registration)
#cancer #preclinical #researc…Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
DATE: December 15, 2025 at 05:30PM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
.@alltrna advances #tRNA-based strategy for stop #codon diseases
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
DATE: December 11, 2025 at 08:25AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: HHS health IT chief hints at a new approach to EHR certification
URL: https://www.statnews.com/2025/12/11/hhs-new-approach-ehr-certification-health-tech/?utm_campaign=rss
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
At a health care AI summit in Washington D.C. yesterday, heavy hitters weighed in on the prospects for interoperability — the effort to make health data currently scattered about the health care system more readily accessible to patients, their providers, and maybe even researchers. A few comments of note:
•This was news to me: Thomas Keane who is the top health IT regulator at HHS said that before Christmas his office hopes to introduce a rule that would eliminate 34 certification criteria for electronic medical records and modify seven. These certification criteria have been much maligned for various reasons including that they create a huge burden on small companies that might want to compete with dominant vendors like Epic Systems.
•
•“We would like the EHR companies to have to do less conformance testing and concern themselves less with this aspect of our regulatory regime,” said Keane. “What we will pivot towards in the spring is regulating the application programming interfaces by which the EHRs talk to each other. And we can say that you have to adopt these features, you have to support this functionality, and if that functionality exists, then these EHRs and other technological applications in the ecosystem should all be able to talk to each other.”
•
•Investor Vijay Pande has resurfaced following his exit from Andreessen Horowitz‘s Bio & Health team earlier this year. He now has a new healthcare AI fund called VZ.VC that he’s not really ready to talk about yet, even though it’s on his LinkedIn profile.
•
•Pande offered an intentionally provocative take on the prospects for interoperability: “I think it’s never going to happen. I think there’s not enough market forces to drive that… I think there’s reasons why we haven’t seen it — It’s not the technology.”
•
Debate on state AI laws heats up
The health AI summit — where I spent most of yesterday a stone’s throw from the White House — was headlined by deputy health secretary Jim O’Neill. I wrapped up a number of his comments in a story, but most provocative was what he didn’t say: When event host Joe Grogan asked about a controversial proposal to prevent states from enforcing their AI laws, O’Neill demurred, saying only that in general he supported fighting state regulation on AI.
Continue to STAT+ to read the full story…
URL: https://www.statnews.com/2025/12/11/hhs-new-approach-ehr-certification-health-tech/?utm_campaign=rss
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
DATE: December 03, 2025 at 11:02AM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
Romidepsin offers hope for high-risk neuroblastoma @GarvanInstitute (free w/ registration)
#cancer #preclinical #research #science #news
https://t.co/SiDLg6tFNrHere are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
DATE: November 19, 2025 at 09:58AM
SOURCE: STAT HEALTH TECHTITLE: STAT+: FDA approval for AI isn’t working. What about medical licenses instead?
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday.
Do you wish your group chat could discuss both the latest Olivia Nuzzi revelations and STAT’s recent RFK Jr. profile … but they don’t all have access to STAT+? Are you already in charge of paying for a family-plan streaming account? Are you looking to have a meet-cute with another STAT reader who also wants to save nearly 45% on a STAT+ subscription?
With STAT’s latest promo, you and up to nine friends(!!) can get reduced rates on STAT+ with a group subscription.
Let me know if you find love in a STAT subscription group; it will be the highlight of my career: [email protected]
A way to get around slow FDA AI regulation
AI in health care is reaching a tipping point. Three things are happening at once.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/category/health-tech/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information..
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor
-
DATE: November 11, 2025 at 03:30PM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
#SouthKorea ramping up investment in
#medicaldevice R&DHere are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
DATE: November 03, 2025 at 05:00PM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
#TCT2025: Cutting balloons match lithotripsy for clearance of calcification
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
